Impact of Gene Polymorphisms on Clinical Outcome for Stage IV ...

Impact of gene polymorphisms on clinical outcome for stage IV ...

Cytokine gene polymorphisms predicted clinical outcome for advanced melanoma patients who received biochemotherapy. The combined effects of multiple genetic ...

Combinations of polymorphisms from multiple genes seem to provide more important prognostic information, which could accurately identify ...

Gene polymorphisms are associated with clinical outcome in ...

The results suggest for the first time that these gene polymorphisms may serve as an independent prognostic marker for LC patients. Keywords: single-nucleotide ...

Immune gene polymorphisms predict overall survival for stage IV ...

We hypothesized that single nucleotide polymorphisms (SNPs) may impact on the clinical outcome for patients treated with biochemotherapy and predict those ...

The impact of DNA damage response gene polymorphisms ... - Nature

Late stage epithelial ovarian cancer has a dismal prognosis. Identification of pharmacogenomic markers (i.e. polymorphisms) to stratify ...

DNA-Repair Gene Polymorphisms Predict Favorable Clinical ...

To avoid the confounding effect of differences in outcome resulting from clinical stage, only stage IV patients (0%. M1) were included in the ...

Correlation of DNA Repair Gene Polymorphisms With Clinical ...

05). In addition, event-free survival was longer for patients with the XPD 312 Asp/Asp genotype compared with patients with Asp/Asn or Asn/Asn ...

Prognostic Impact of Polymorphisms in the CASPASE Genes on ...

Univariate and multivariate survival analysis including pathologic stage, patient age, differentiation, and carcinoembryonic antigen level ...

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs ...

Approximately 80% of NSCLC patients are diagnosed as advanced (phase IIIA/B) or metastatic (phase IV) stages of the disease [2], which results ...

Genetic polymorphisms affecting clinical outcomes in epithelial ...

Genetic polymorphisms such as ERCC1 8092C>A, ABCB1 2677G>T/A, GSTP1 I105V and GSTT1 polymorphisms may affect drug response, toxicity and survival in patient ...

Genetic Polymorphisms and Platinum-Based Chemotherapy ...

No significant correlation was detected between the A2251C polymorphism and grade 3–4 hematological toxicity (OR = 1.00, 95% CI: 0.55–1.85, P = ...

DNA repair gene polymorphisms and clinical outcome of patients ...

The presence of at least three polymorphic variants in certain DNA repair genes may impact on patient survival and could be a potential genomic ...

Predictive Value of XRCC1 Gene Polymorphisms on Platinum ...

The relationship between XRCC1 gene polymorphisms (Arg399Gln and Arg194Trp) and clinical outcome (response rate and overall survival) in Pt-chemo for advanced ...

Vascular endothelial growth factor gene polymorphisms associated ...

Results: The survival analysis showed no association of three VEGF gene polymorphisms with the prognosis. For the +936C > T polymorphism, the T/T genotype, ...

Effects of gene polymorphisms in the endoplasmic reticulum stress ...

The effects of gene polymorphisms on clinical outcomes ... Because TNM stage is the main criterion for predicting prognosis in NPC patients, ...

The impacts of genetic polymorphisms in genes of base excision ...

They also analyzed 125 patients with stage IV disease and found that patients ... clinical outcomes of chemoradiotherapy in Chinese patients ...

Impact of Gene Polymorphisms on Clinical Outcome for Stage IV ...

Impact of Gene Polymorphisms on Clinical Outcome for Stage IV Melanoma Patients Treated with Biochemotherapy: An Exploratory Study. Published in.

Impact of CTLA4 genotype and other immune response gene ...

, et al. Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation . Bone Marrow ...

Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical ...

These polymorphisms independently predicted clinical outcome even after taking into account age, gender, tumour histology, tumour differentiation and ...

FAS and FASL genetic polymorphisms impact on clinical outcome of ...

FASL-844 CC genotype was more common than expected in early-stage tumor (P=0.042). It was found that there was no association between the ...